´ëÇѳ»ºÐºñÇÐȸ Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°Á : 2021-06-19±³À°ÀÏÀÚ : 2021-06-19
±³À°Àå¼Ò : ¿Â¶óÀα³À°
±³À°ÁÖÁ¦ :
Á¦19ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : È«Áö¼ö
¿¬¶ôó : 02-2038-3771
À̸ÞÀÏ :
endo@endocrinology.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í ºÀÁ÷ÀÇ/°³¿øÀÇ 5¸¸¿ø (ºñȸ¿ø 7¸¸¿ø)Àü°øÀÇ ¹× ±âŸ(±âÃÊÀÇÇÐÀÚ/°£È£»ç/¾à»ç µî) 3¸¸¿ø(ºñȸ¿ø 5¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-19 ÿ½Ã 09:00~09:25 Coping with side effects of anti-thyroid drugs ¹Ú¿µÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 09:25~09:50 Can we surely watch out for papillary thyroid microcarcinoma with active surveillance? ±è¿ø¹è(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 09:50~10:15 Digging up the combination effects of T3 and T4 ±èº¸Çö(ºÎ»êÀÇ´ë)
ÈÞ½Ä 06-19 10:15~10:25 Break ()
±³À°½Ã°£ 06-19 ÿ½Ã 10:25~10:50 Basic concept of bone modeling and remodeling Á¤È£¿¬(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 10:50~11:15 Long-term complications in patients with hypoparathyroidism À̽ÃÈÆ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 11:15~11:40 Long-term strategy in management of osteoporosis ±èºÎ°æ(°í½ÅÀÇ´ë)
ÈÞ½Ä 06-19 11:40~11:50 Break ()
±³À°½Ã°£ 06-19 ÿ½Ã 11:50~12:15 Management of hyperprolactinemia (except for prolactinomas) Áø»ó¿í(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 12:15~12:40 Diagnosis and management of diabetes insipidus ±èÇý¼ø(°è¸íÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 12:40~13:05 Novel approach to multiple endocrine neoplasia type 1 ±èÁ¤Èñ(¼¿ïÀÇ´ë)
ÈÞ½Ä 06-19 13:05~13:30 ½Ä»ç ()
±³À°½Ã°£ 06-19 ÿ½Ã 13:30~13:55 Update on the diagnosis and genetics of pheochromocytoma/paraganglioma ±èÀçÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 13:55~14:20 Diagnosis and management of polycystic ovary syndrome: Endocrinologist¡¯s viewpoint ÀÌÇýÁø(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 14:20~14:55 Male hypogonadism – diagnosis and treatment Á¶¹Îö(¼¿ïÀÇ´ë)
ÈÞ½Ä 06-19 14:55~15:05 Break ()
±³À°½Ã°£ 06-19 ÿ½Ã 15:05~15:30 Effects of GLP-1 receptor agonist on cardiovascular disease ¿À½ÂÁØ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 15:30~15:55 Recent research for SGLT2 inhibitor and chronic kidney disease Çö¿µÀ²(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-19 ÿ½Ã 15:55~16:20 Beneficial effect of initial combination therapy in patients with T2DM ±è´ëÁß(¾ÆÁÖÀÇ´ë)